A cardiologist has countersued the American Home Products
Settlement Trust, alleging a racketeering conspiracy to destroy her
reputation and livelihood as a cover for the trust's effective bankruptcy
and Wyeth's significant underestimation of the number of opt-out plaintiffs
it faces.
Linda Crouse, M.D., argues in her Feb. 24 counterclaim that some of the
echocardiographic tapes cited by the trust as evidence of her wrongdoing in
its Sept. 18 complaint were found to be medically reasonable by the trust's
own expert or auditing cardiologists. Crouse says the trust is now using
films of hers that its expert previously certified as showing injury as
examples of nonqualifying echoes to train its auditors to reject legitimate
claims.
Crouse says an alleged conspiracy was set in motion during a hearing in
September 2002 into matrix claims filed by two New York law firms using
Crouse's echocardiograms and those of another cardiologist. At those
hearings, Crouse says, the trust and its expert, John M. Dent, M.D.,
developed the theory that what Crouse had interpreted as regurgitation of
the mitral valve was a harmless phenomenon called "backflow." Crouse
responds that backflow is not a medically recognized term and that the
settings of her echocardiogram machine eliminate any spurious artifacts that
could be incorrectly interpreted as regurgitation. Since then, Crouse says,
her practice has fallen off and prestigious professional organizations have
distanced themselves from her.
"The September 2002 Hearing and the events leading up to it, were but a
small piece of a larger scheme by the Trustees and Wyeth, with the approval
and complicity of the PMC [Plaintiffs' Management Committee], to cover up
the now obvious facts that (1) the Trust is under-funded and is effectively
bankrupt; (2) Wyeth, the PMC and the Trustees seriously underestimated the
number of claimants likely to qualify for Matrix Benefits; (3) there were
serious errors in the criteria to qualify for Matrix Benefits, and in the
protocols for submitting claims, such that many members of the general
population who took the Diet Drugs but may not be considered to be FDA
Positive in a clinical setting nevertheless qualify for substantial Matrix
Benefits under the Settlement Agreement; and (4) the Trust has been
seriously mismanaged," Crouse says.
The lawsuits against Crouse and another cardiologist are an attempt to cover
for the fact that the definition of moderate mitral regurgitation in the
Settlement Agreement is obsolete and allows people to qualify for
compensation although a cardiologist would not find that person to be
injured in a clinical setting, Crouse says.
03/18/04